Kuwait vs Syrian Arab Republic: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Kuwait
- Syrian Arab Republic
How they compare
Kuwait currently reports 27 deaths against 24.99 deaths in Syrian Arab Republic, a difference of 2.01 deaths.
That makes Kuwait's figure about 1.1 times Syrian Arab Republic's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Syrian Arab Republic ahead.
Kuwait ranks 144th and Syrian Arab Republic ranks 146th of 157 countries.
Kuwait has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Kuwait | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 1.5 deaths | 0 deaths | 1.5 deaths | Kuwait |
| 2000s | 6.3 deaths | 2.4 deaths | 3.9 deaths | Kuwait |
| 2010s | 15.7 deaths | 10.03 deaths | 5.67 deaths | Kuwait |
| 2020s | 25.33 deaths | 19.45 deaths | 5.88 deaths | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Kuwait or Syrian Arab Republic?
- Kuwait, at 27 deaths against 24.99 deaths in Syrian Arab Republic as of 2022.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Kuwait and Syrian Arab Republic?
- 2.01 deaths, with Kuwait ahead.
- How many years of comparable data are there for Kuwait and Syrian Arab Republic?
- 33 years are reported by both, from 1990 to 2022.
- How do Kuwait and Syrian Arab Republic rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Kuwait ranks 144th and Syrian Arab Republic ranks 146th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.